Existing evidence does not adequately evaluate the effects with consideration of the patients’ past history of tobacco use and the tobacco use during and after cancer treatment. The toxicity and expense of many cancer therapies warrant a better understanding of how concurrent tobacco use undermines efficacy or increases morbidity.
Showing 3 ideas for tag "tobacco"
Survey pregnant women and their health professionals to determine levels of awareness about smoking, e-cigarettes, nicotine replacement products, and alcohol consumption. Determine when/if information is provided to pregnant women, evaluate the accuracy of the information, and assess its effectiveness. Cotinine measurements could be used as a surrogate for nicotine consumption. Alcohol use could be assessed by surveys... more »
Lung cancer screening (LCS) may provide an opportunity to deliver smoking cessation treatments to particularly receptive individuals. Receiving LCS is associated with high risk perception and increased motivation to quit. Conversely, motivation to quit might be decreased for individuals with negative findings. Appropriately designed cessation interventions can increase and leverage LCS patients' motivation to quit smoking.... more »